MARC N. CASPER - 02 Nov 2022 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Chairman & CEO, Director
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Issuer symbol
TMO
Transactions as of
02 Nov 2022
Net transactions value
-$3,997,056
Form type
4
Filing time
04 Nov 2022, 16:49:47 UTC
Previous filing
02 Nov 2022
Next filing
08 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Sale $386,504 -800 -0.43% $483.13 185,405 03 Nov 2022 Direct F1, F2
transaction TMO Common Stock Sale $160,685 -332 -0.18% $483.99 185,073 03 Nov 2022 Direct F1, F3
transaction TMO Common Stock Sale $97,092 -200 -0.11% $485.46 184,873 03 Nov 2022 Direct F1, F4
transaction TMO Common Stock Sale $961,956 -1,976 -1.1% $486.82 182,897 03 Nov 2022 Direct F1, F5
transaction TMO Common Stock Sale $1,053,756 -2,160 -1.2% $487.85 180,737 03 Nov 2022 Direct F1, F6
transaction TMO Common Stock Sale $797,999 -1,632 -0.9% $488.97 179,105 03 Nov 2022 Direct F1, F7
transaction TMO Common Stock Sale $489,990 -1,000 -0.56% $489.99 178,105 03 Nov 2022 Direct F1, F8
transaction TMO Common Stock Sale $49,074 -100 -0.06% $490.74 178,005 03 Nov 2022 Direct F1
holding TMO Common Stock 2,000 02 Nov 2022 By Alison Casper 2020 Irrevocable Trust F9
holding TMO Common Stock 89,155 02 Nov 2022 By Floral Park Associates, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $482.52 to $483.48, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), and (8) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $483.64 to $484.44, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $485.25 to $485.66, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $486.41 to $487.35, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $487.42 to $488.32, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $488.49 to $489.40, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $489.59 to $490.49, inclusive.
F9 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.

Remarks:

One of two Form 4's filed on November 4, 2022 for the reporting of transactions occurring on November 2, 2022 and November 3, 2022, both partially included in the first Form 4. The second Form 4 includes additional transactions occurring on November 3, 2022 that could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4.